The Food and Drug Administration on Friday allowed the emergency use of Gilead's remdesivir that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The regulator cleared Gilead Science’s intravenous drug for hospitalized patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators.
The Food and Drug Administration on Friday allowed the emergency use of Gilead's remdesivir that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The regulator cleared Gilead Science’s intravenous drug for hospitalized patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators. May 02, 2020 at 07:13AM https://ift.tt/2KQKWCT
No comments:
Post a Comment